MSN Laboratories Private Limited Posaconazole Export Data — India (DGFT 2022–2026)

Name: MSN Laboratories Private Limited Posaconazole Export Records India — #4 Exporter, 8 Shipments, $307.2K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Posaconazole

India Pharmaceutical Trade Intelligence

$115.1M51 Suppliers41 CountriesHS 30049099

ExportsIndia → UNITED STATES79.5%India → CYPRUS8.5%

ImportsBELGIUM → India$367.8K UNITED STATES → India$254.9K

#1 Supplier: AET LABORATORIES

MSN Laboratories Private Limited — Posaconazole Exporter #4 | $307.2K Trade Value | TransData Nexus | TransData Nexus

MSN Laboratories Private Limited — Posaconazole Exporter Profile

Indian Pharmaceutical Exporter · #4 for Posaconazole · $307.2K export value · DGFT Verified

MSN Laboratories Private Limited is the #4 Indian exporter of Posaconazole with $307.2K in export value and 8 verified shipments. MSN Laboratories Private Limited holds a 0.3% market share in Posaconazole exports across 3 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.

MSN Laboratories Private Limited — Posaconazole Export Profile: Buyers & Destinations

MSN Laboratories Private Limited Posaconazole export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Posaconazole?

Country	Value	Shipments	Share
UNITED STATES	$3.0M	60	32.8%
CYPRUS	$1.5M	30	16.4%
CZECH REPUBLIC	$1.4M	29	15.9%
AUSTRALIA	$1.0M	20

Who Are the Top Buyers of Posaconazole from India?

Buyer	Country	Value	Orders
MEDIS INTERNATIONAL A.S,	CZECH REPUBLIC	$900.0K	18
DELORBIS PHARMACEUTICALS LTD	CYPRUS	$600.0K	12
HEALTHCARE LOGISTICS	AUSTRALIA	$600.0K	12
M/S. DELORBIS PHARMACEUTICALS LTD.	CYPRUS	$400.0K	8
ACCORD HEALTHCARE LTD.,	UNITED KINGDOM	$350.0K	7
DELORBIS PHARMACEUTICALS LIMITED	CYPRUS	$300.0K	6
MEDIS INTERNATIONAL A S	CZECH REPUBLIC	$250.0K	5
EUGIA US LLC,	UNITED STATES	$100.0K	2
XX REXXYS XXBORXXORIXX INXX	UNITED STATES	$100.0K	2
DELORBLS PHARMACEUTICALS LTD	CYPRUS	$100.0K	2

India's Posaconazole is purchased by 105 buyers worldwide. The top buyer is MEDIS INTERNATIONAL A.S, (CZECH REPUBLIC), followed by DELORBIS PHARMACEUTICALS LTD and HEALTHCARE LOGISTICS.

How Does MSN Laboratories Private Limited Compare to Nearest Posaconazole Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	AET LABORATORIES PRIVATE LIMITED	$6.0M	121	9	$50.0K
2	HETERO LABS LIMITED	$1.5M	30	6	$50.0K
4	MSN LABORATORIES PRIVATE LIMITED ★	$307.2K	8	3	$38.4K
3	GLAND PHARMA LTD	$300.0K	6	1	$50.0K
5	RESCUERS LIFE SCIENCES LIMITED	$74.5K	5	1	$14.9K

MSN Laboratories Private Limited ranks #4 among 51 Indian Posaconazole exporters. Average shipment value of $38.4K compared to the market average of $161.9K. The closest competitors by value are AET LABORATORIES PRIVATE LIMITED and HETERO LABS LIMITED.

Which Indian Ports Ship Posaconazole Exports?

Port	Shipments	% Share
HYDERABAD AIR	56	20.4%
SAHAR AIR	33	12.0%
SAHAR AIR CARGO ACC (INBOM4)	27	9.9%
HYDERABAD ACC (INHYD4)	26	9.5%
DELHI AIR CARGO ACC (INDEL4)	13	4.7%
DELHI AIR	12	4.4%
BANGALORE AIR	11	4.0%
NHAVA SHEVA SEA (INNSA1)	10	3.6%

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Posaconazole Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.

MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Posaconazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 41+ countries, 105+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Posaconazole

Posaconazole

MSN Laboratories Private Limited — Posaconazole Exporter Profile

MSN Laboratories Private Limited — Posaconazole Export Profile: Buyers & Destinations

Where Does India Export Posaconazole?

Who Are the Top Buyers of Posaconazole from India?

What Is India's Total Posaconazole Export Value and How Much Does MSN Laboratories Private Limited Contribute?

What Is the Average Shipment Value for MSN Laboratories Private Limited's Posaconazole Exports?

How Does MSN Laboratories Private Limited Compare to Other Indian Posaconazole Exporters?

Regulatory Requirements: Exporting Posaconazole to Key Markets

United States — FDA

Australia — TGA

How Does MSN Laboratories Private Limited Compare to Nearest Posaconazole Exporters?

Which Indian Ports Ship Posaconazole Exports?

What Other Advanced Antifungals Products Does MSN Laboratories Private Limited Export?

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Posaconazole Exports

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

About MSN Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Posaconazole Export Data from MSN Laboratories Private Limited

Posaconazole Stats

Company Overview

Top Products by MSN Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source